EDITORIAL
Published on 11 Dec 2024
Editorial: Commercialization and industrialization in experimental pharmacology and drug discovery: 2023
doi 10.3389/fphar.2024.1528987
- 219 views
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- Commercialization and Industrialization in Experimental Pharmacology and Drug Discovery: 2023
Commercialization and Industrialization in Experimental Pharmacology and Drug Discovery: 2023
3,667
Total downloads
14k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 24 Oct 2024
Deciphering quinazoline derivatives’ interactions with EGFR: a computational quest for advanced cancer therapy through 3D-QSAR, virtual screening, and MD simulations
doi 10.3389/fphar.2024.1399372
- 573 views
REVIEW
Published on 01 Oct 2024
The versatile multi-functional substance NMN: its unique characteristics, metabolic properties, pharmacodynamic effects, clinical trials, and diverse applications
doi 10.3389/fphar.2024.1436597
- 3,329 views
ORIGINAL RESEARCH
Published on 21 Aug 2024
Transcriptome analysis of the aged SAMP8 mouse model of Alzheimer’s disease reveals novel molecular targets of formononetin protection
doi 10.3389/fphar.2024.1440515
- 790 views
- 1 citation
ORIGINAL RESEARCH
Published on 21 May 2024
Investigating Sulforaphane’s anti-virulence and anti-quorum sensing properties against Pseudomonas aeruginosa
doi 10.3389/fphar.2024.1406653
- 1,172 views
- 1 citation
ORIGINAL RESEARCH
Published on 12 Mar 2024
Redirecting pantoprazole as a metallo-beta-lactamase inhibitor in carbapenem-resistant Klebsiella pneumoniae
doi 10.3389/fphar.2024.1366459
- 1,510 views
- 2 citations
PERSPECTIVE
Published on 01 Feb 2024
Examining the clinical relevance of metformin as an antioxidant intervention
doi 10.3389/fphar.2024.1330797
- 2,729 views
- 8 citations
ORIGINAL RESEARCH
Published on 29 Jan 2024
Aloe-emodin exhibits growth-suppressive effects on androgen-independent human prostate cancer DU145 cells via inhibiting the Wnt/β-catenin signaling pathway: an in vitro and in silico study
doi 10.3389/fphar.2023.1325184
- 1,477 views
- 2 citations
Published in
Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Translational Pharmacology
Impact
- 14kTopic views
- 9,939Article views
- 3,667Article downloads